论文部分内容阅读
从长期来看,高血压病患者的降压治疗可以显著降低出血性和缺血性脑卒中的发生和复发。对于蛛网膜下腔出血、脑出血或急性缺血性脑卒中的患者,在发病后的急性期,血压控制的最佳目标血压水平是不确定的。关于脑卒中后立即行血压控制的最佳血压水平的临床试验证据是有限和有争议的。脑卒中患者的血压控制主要是依据普通人群血压控制的指南,辅以基于小样本病例研究的专家建议。脑卒中是一种异质性疾病,适当的血压控制,其效果因不同类型脑卒中的发病机制不同而异。
In the long run, antihypertensive therapy in hypertensive patients can significantly reduce the occurrence and recurrence of hemorrhagic and ischemic stroke. For patients with subarachnoid hemorrhage, cerebral hemorrhage or acute ischemic stroke, the optimal target blood pressure level for blood pressure control is uncertain during the acute post-morbid period. Clinical trial evidence on the optimal blood pressure level for stroke control immediately after stroke is limited and controversial. Blood pressure control in stroke patients is based primarily on general population blood pressure guidelines, supplemented by expert advice based on small sample case studies. Stroke is a heterogeneous disease with proper blood pressure control and its effects vary according to the pathogenesis of different types of stroke.